Lycopene attenuates endothelial dysfunction in streptozotocin-induced diabetic rats by reducing oxidative stress

Pharmaceutical Biology

Volumn 49, Issue 11, 2011, Pages 1144-1149

  Zhu, Jing ^a   Wang, Chun Ge ^a   Xu, Yan Gui ^a  

^a TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

Antioxidant; Cardiovascular complications; Diabetes mellitus; Natural products; Nitric oxide

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN; LYCOPENE; MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES; VASODILATATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; BLOOD GLUCOSE; CAROTENOIDS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; LIPIDS; MALE; MALONDIALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; VASODILATION;

RATTUS;

EID: 80054898021     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2011.574707     Document Type: Article

References (25)

1. Ali MM, Agha FG. (2009). Amelioration of streptozotocin-induced diabetes mellitus, oxidative stress and dyslipidemia in rats by tomato extract lycopene. Scand J Clin Lab Invest, 69, 371-379.
2. Bardell AL, MacLeod KM. (2001). Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats. J Pharmacol Exp Ther, 296, 252-259.
3. Britton G. (1995). Structure and properties of carotenoids in relation to function. FASEB J, 9, 1551-1558.
4. Cai H, Harrison DG. (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res, 87, 840-844.
5. Calles-Escandon J, Cipolla M. (2001). Diabetes and endothelial dysfunction: A clinical perspective. Endocr Rev, 22, 36-52.
6. Chen YS, Zhu XX, Zhao XY, Xing HY, Li YG. (2008). Hemin, a heme oxygenase-1 inducer, improves aortic endothelial dysfunction in insulin resistant rats. Chin Med J, 121, 241-247.
7. Clinton SK. (1998). Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev, 56, 35-51.
8. Coccheri S. (2007). Approaches to prevention of cardiovascular complications and events in diabetes mellitus. Drugs, 67, 997-1026.
9. El-Missiry MA, El Gindy AM. (2000). Amelioration of alloxan induced diabetes mellitus and oxidative stress in rats by oil of Eruca sativa seeds. Ann Nutr Metab, 44, 97-100.
10. Gerster H. (1997). The potential role of lycopene for human health. J Am Coll Nutr, 16, 109-126.
11. Institute for Laboratory Animal Research. (1996). Guide for the Care and Use of Laboratory Animals. Washington, D.C.: National Academy Press.
12. Jin BH, Qian LB, Chen S, Li J, Wang HP, Bruce IC, Lin J, Xia Q. (2009). Apigenin protects endothelium-dependent relaxation of rat aorta against oxidative stress. Eur J Pharmacol, 616, 200-205.
13. Kuhad A, Sethi R, Chopra K. (2008). Lycopene attenuates diabetesassociated cognitive decline in rats. Life Sci, 83, 128-134.
14. Lu J, Zhu SM, Zang WJ, Xu XL, Luo HL, Yu XJ, Wang SP, Kong SS, Wu J, Horie M, Sun L. (2007). Protective mechanism of adenosine to the rat arterial endothelial dysfunction induced by hydrogen peroxide. Biol Pharm Bull, 30, 1206-1211.
15. Maritim AC, Sanders RA, Watkins JB 3rd. (2003). Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol, 17, 24-38.
16. Ohkawa H, Ohishi N, Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem, 95, 351-358.
17. Qian LB, Wang HP, Chen Y, Chen FX, Ma YY, Bruce IC, Xia Q. (2010). Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress. Pharmacol Res, 61, 281-287.
18. Rao AV, Rao LG. (2007). Carotenoids and human health. Pharmacol Res, 55, 207-216.
19. Riccioni G. (2009). Carotenoids and cardiovascular disease. Curr Atheroscler Rep, 11, 434-439.
20. Riccioni G, Mancini B, Di Ilio E, Bucciarelli T, DOrazio N. (2008). Protective effect of lycopene in cardiovascular disease. Eur Rev Med Pharmacol Sci, 12, 183-190.
21. Rodríguez-Mañas L, Angulo J, Vallejo S, Peiró C, Sánchez-Ferrer A, Cercas E, López-Dóriga P, Sánchez-Ferrer CF. (2003). Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature. Diabetologia, 46, 556-566.
22. Schäfer A, Fraccarollo D, Pförtsch S, Flierl U, Vogt C, Pfrang J, Kobsar A, Renné T, Eigenthaler M, Ertl G, Bauersachs J. (2008). Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus. Br J Pharmacol, 153, 886-893.
23. Sena CM, Nunes E, Louro T, Proença T, Fernandes R, Boarder MR, Seiça RM. (2008). Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. Br J Pharmacol, 153, 894-906.
24. Smith JM, Sondgeroth KB, Wahler GM. (2007). Inhibition of nitric oxide synthase enhances contractile response of ventricular myocytes from streptozotocin-diabetic rats. Mol Cell Biochem, 300, 129-137.
25. Wang C, Li J, Lv X, Zhang M, Song Y, Chen L, Liu Y. (2009). Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin. Eur J Pharmacol, 620, 131-137.